3/28/2023 0 Comments Void bastards outpatient weak spot![]() ![]() The ACC/AHA Task Force on Clinical Practice Guidelines (Task Force) continuously reviews, updates, and modifies guideline methodology on the basis of published standards from organizations, including the Institute of Medicine, P-3,P-4 and on the basis of internal reevaluation. Guidelines are official policy of the ACC and AHA. The ACC and AHA sponsor the development and publication of guidelines without commercial support, and members of each organization volunteer their time to the writing and review efforts. These guidelines, which are based on systematic methods to evaluate and classify evidence, provide a cornerstone for quality cardiovascular care. Under the management of the ACC/AHA Task Force, a Prevention Subcommittee was appointed to help guide development of the suite of guidelines on prevention of cardiovascular disease (CVD). In 2014, the ACC and AHA, in partnership with several other professional societies, initiated a guideline on the prevention, detection, evaluation, and management of high blood pressure (BP) in adults. P-1,P-2 Accordingly, the ACC and AHA collaborated with the NHLBI and stakeholder and professional organizations to complete and publish 4 guidelines (on assessment of cardiovascular risk, lifestyle modifications to reduce cardiovascular risk, management of blood cholesterol in adults, and management of overweight and obesity in adults) to make them available to the widest possible constituency. In 2013, the National Heart, Lung, and Blood Institute (NHLBI) Advisory Council recommended that the NHLBI focus specifically on reviewing the highest-quality evidence and partner with other organizations to develop recommendations. Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines (guidelines) with recommendations to improve cardiovascular health. Reviewer Relationships With Industry and Other Entities (Comprehensive) 1319 Summary of BP Thresholds and Goals for Pharmacological Therapy 1304Īuthor Relationships With Industry and Other Entities (Relevant) 1317 The Plan of Care for Hypertension 1302 13.1.Īccess to Health Insurance and Medication Assistance Plans 1303 Improving Quality of Care for Patients With Hypertension 1302 12.4.1. Telehealth Interventions to Improve Hypertension Control 1302 Health Information Technology–Based Strategies to Promote Hypertension Control 1302 12.3.1. Structured, Team-Based Care Interventions for Hypertension Control 1301 ![]() Strategies to Promote Lifestyle Modification 1301 Strategies to Improve Hypertension Treatment and Control 1301 12.1.Īdherence Strategies for Treatment of Hypertension 1301 12.1.1.Īntihypertensive Medication Adherence Strategies 1301 Patients Undergoing Surgical Procedures 1301 Hypertensive Crises-Emergencies and Urgencies 1298 Racial and Ethnic Differences in Treatment 1296 Hypertension After Renal Transplantation 1292 Heart Failure With Preserved Ejection Fraction 1292 Heart Failure With Reduced Ejection Fraction 1292 Hypertension in Patients With Comorbidities 1291 9.1. Monitoring Strategies to Improve Control of BP in Patients on Drug Therapy for High BP 1291 Initiation of Pharmacological BP Treatment in the Context of Overall CVD Risk 1286īP Treatment Threshold and the Use of CVD Risk Estimation to Guide Drug Treatment of Hypertension 1286įollow-Up After Initial BP Evaluation 1287īP Goal for Patients With Hypertension 1290įollow-Up of BP During Antihypertensive Drug Therapy 1290 8.2.1.įollow-Up After Initiating Antihypertensive Drug Therapy 1290 Laboratory Tests and Other Diagnostic Procedures 1286 Secondary Forms of Hypertension 1281 5.1.1.ĭrugs and Other Substances With Potential to Impair BP Control 1283 Out-of-Office and Self-Monitoring of BP 1278 Organization of the Writing Committee 1273Ĭoexistence of Hypertension and Related Chronic Conditions 1276Īccurate Measurement of BP in the Office 1277 Customer Service and Ordering InformationĢ017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Stroke: Vascular and Interventional Neurology.Journal of the American Heart Association (JAHA).Circ: Cardiovascular Quality & Outcomes.Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |